A B S T R A C T Viable rat islet cells were used to detect islet cell surface antibodies (ICSA) in the sera of diabetic and control patients. ICSA were present in almost all recent-onset insulin-dependent diabetics younger than 30 yr (15/16); their incidence in other diabetics (6/22) was also higher than in normal controls (1/18) or in patients with autoimmune thyroiditis (1/12) . The varying specificity of the ICSA for the different islet cell types led to the recognition of class I sera, whose ICSA bind exclusively to B cells, class II sera, binding only to A and pancreatic polypeptide (PP) cells and class III sera, reacting with the three islet cell types but not with D cells. Most recent-onset insulin-dependent diabetics younger than 30 contained class I-ICSA, which is consistent with an autoimmune basis of their disease and with an involvement of surface antibodies in the B cell destruction. The presence of class II ICSA in three older diabetics and in one normal control raises the question whether autoimmune reactions against A and PP cells exist and are -associated with a distinct entity in islet disease.
It is concluded that the autoimmune form of diabetes mellitus represents a heterogeneous group, in which ICSA-positive patients can be distinguished on the basis of their ICSA-binding to one or more islet cell types.
Three techniques can be used for the further identification of circulating ICSA, namely binding experiments with purified A or B cells, electron microscopical analysis of ICSA-binding islet cells purified by fluorescence-activated cell sorting, and the immunocytochemical characterization of ICSA-positive cells.
(IDDM)' was first suggested by the lymphocytic infiltration of the islets of recently diagnosed insulin dependent diabetics (1) and was later documented by the description of cellular and humoral autoimmune processes at the onset of the insulin dependency (2) (3) (4) (5) (6) (7) (8) .
It has often been proposed that the immune reactivity to pancreatic islet cells is directly responsible for the massive B cell destruction in IDDM; this hypothesis was recently supported by the in vitro observation that lymphocytes as well as circulating antibodies from IDDM inhibit glucose-induced insulin release and damage mammalian islet cells (9) (10) (11) IDDM were defined on the basis of their susceptibility to ketosis and were examined within 1 wk after diagnosis; all noninsulin-dependent diabetics presented a fasting hyperglycemia and glucosuria at the time of diagnosis and were studied within 5 yr after diagnosis. The sera were stored at -20°C until heat inactivation (56°C, 20 min) and ammonium sulphate precipitation (first at 50% saturation, then at 33%); the precipitated immunoglobulins were dissolved in phosphate-buffered saline (PBS, pH 7.4), then dialyzed against the same buffer for 36 h at 4°C, and finally frozen in 100-jl aliquots. Before use, the antibodies were centri-'Abbreviations used in this paper: ICA, circulating islet cell antibodies; ICSA, islet cell surface antibodies; IDDM, insulin-dependent diabetes mellitus; KRH [12] ), supplemented with 0.02 g/100 ml sodium azide and 1 g/100 ml bovine serum albumin ( (8) .
Sorting of ICSA-positive cells. ICSA-positive cells were separated from ICSA-negative cells by fluorescence-activated cell sorting (13) , using a FACS IV (Becton-Dickinson Co., Sunnyvale, CA). The fluorescence emitted by rhodamine-labeled cells was selected as sorting parameter; a 171-01 Krypton laser (520 nm-120 mW; Spectra-Physics, Inc., Mountain View, CA) was used for excitation and an LP 580 filter (Ditric Optics, Inc., Marlboro, MA) for emission detection; PMT voltage was 750 V and the conversion gain of the fluorescence 8 X 0.5. Sorting was carried out in KRH noCa at 17°C. The cell separation was evaluated by comparing visually the membrane fluorescence of the sorted positive and negative cells. Sorted cells were also processed for electron microscopy, fixing them at 20°C in 4.5% (vol/ vol) glutaraldehyde (0.1 mol/liter phosphate buffer, pH 7.4) and postfixing in 1% (wt/vol) Os04; after staining the cells with 5% (wt/vol) uranylacetate, they were pelleted in an Eppendorf microfuge tube and covered with 10 Ml fibrinogen (1% wt/vol) and 2 Ml thrombin (2,000 IU/ml); just before complete coagulation, most of the supernatant was removed and the cells, covered with an ultrathin fibrin layer, were dehydrated in successively 25 The percent positive islet cells varied also from 30-90% for the different sera tested. It was however noted that certain sera bound exclusively to the larger islet cells, whereas others reacted only with the smaller cells (Fig. 1) . As On the basis of these observations, the ICSA-positive sera were subdivided in class I (B cell specific), class II (non-B cell specific), and class III (binding to B and non-B cells) (Table II) . This heterogeneity in specificity for different islet cell types was also evident from electron micrographs of the ICSA-positive cells. In these experiments, dissociated islet cells were incubated with sera from class I or II, then exposed to rhodamine-labeled anti-human antibodies and finally sorted on the basis of rhodamine fluorescence. After appropriate window setting, the fluorescence-activated cell sorter separated the rhodamine positive cells from the negative ones (Fig. 2) and resulted in the purification of the ICSA-positive cells. When the ICSA-positive cells were examined electron microscopically, >95% of the cells corresponded to B cells for class I sera (Fig. 3a) ; islet cells binding to class II sera consisted on the other hand for 80% of A cells (Fig. 3b) mones and examined for the presence of a fluoresceinpositive cytoplasm. These double-label experiments indicated that the ICSA from class I bound to insulincontaining cells and not to glucagon-containing cells (Fig. 4) . Class II ICSA reacted on the other hand with cells staining positively for glucagon or pancreatic polypeptide, but not for insulin or somatostatin (Fig.  4) ; it thus turned out that for class II sera 80-90% of the ICSA-positive cells were glucagon-containing cells .." z.
IDDM, especially at the time of diagnosis, and hence to an argument in favor of the autoimmune basis of the disease (5, 15) . The subsequent reports on the ICAbinding to both B cell and non-B cell cytoplasm and the detection of ICA in nondiabetic subjects questioned, however, the role of ICA in the destruction process of pancreatic B-cells; circulating ICA were therefore considered as a marker for the risk of developing an insulin-dependent state (16) (17) (18) . The more recent observation that many newly diagnosed insulin-dependent diabetics present ICSA (8) , which provoke a complement-mediated cytotoxicity in vitro (10, 11) , raises however again the question whether circulating antibodies are actively involved in the pathogenesis of the disease. It seems therefore appropriate to examine whether diabetic ICSA bind specifically to B cells and whether such antibodies also occur in nondiabetic subjects. In the one report which has so far dealt with this question (11) , both insulinsynthetizing and somatostatin-synthetizing cells were equally sensitive to the cytotoxic effect of diabetic ICSA, suggesting a lack of specificity. As these studies were performed with cloned islet cells, their extrapolation to the normal situation certainly requires confirmation on normal cell preparations. In the present experiments, ICSA-binding was studied on normal rat islet cells, and its specificity tested by comparing binding with purified B and non-B cells. The islet cells that bind to ICSA were also identified electron microscopically and immunocytochemically.
All sera were first screened for ICSA using unpurified islet cell preparations. Binding of human antibodies to rat islet cell membranes was visualized by a positive rhodamine fluorescent reaction. No fluorescent rings were observed with one group of sera, including most control subjects (ICSA-negative), whereas 30-90% of the islet cells displayed rhodamine-positive membranes with many diabetic sera (ICSA-positive). For each ICSA-positive serum, a relatively constant percent positive cells was found throughout the experiments; most sera bound to large-sized islet cells, but some sera reacted exclusively with the smaller cells. These results suggest a heterogeneity in the ICSA-positive sera with respect to their affinity for the various islet cell types. Rat (65% B, 23% A, 8% D, 4% PP) , 65% positive cells can be expected for class I sera, 30% for class II sera, and 95% for class III sera, which is consistent with the data.
The present results confirm the higher incidence of ICSA in recent-onset IDDM as compared with normal controls (8, 10, 18) . It 
